Payer

The Oregon Health Authority said the deal is not likely to greatly reduce access to affordable care in the state, but it placed some conditions on its approval.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

Nomi Health appointed its first chief product officer, and Hims & Hers announced that its first chief medical officer has returned to the role.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.

United Language Group's Leslie Iburg and Abigail Katz discuss the expiration of the federal public health emergency and what is needed to reach beneficiaries, including creating culturally relevant materials in multiple languages.

The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.

The startup offers access to advocates who can help family caregivers make plans or solve problems as well as a digital health platform.

Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.